Neurontin (Gabapentin)

Gabapentin binds to the α2δ subunit of voltage‑gated calcium channels in the central nervous system. This binding limits calcium entry into neurons, decreasing the release of excitatory neurotransmitters and thereby reducing neuronal hyperexcitability that underlies seizures and neuropathic pain.

The appropriate dose of Neurontin is individualized by a prescriber based on the specific indication, patient age, renal function, and response to therapy. Healthcare professionals determine the starting dose and any necessary titration.

Safety data for gabapentin in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by the treating physician in consultation with the patient.

To request Neurontin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with other agents such as pregabalin, gabapentin has a similar mechanism but may require higher doses and more frequent titration. Both are anticonvulsants used for neuropathic pain, yet individual response, side‑effect profile, and renal dosing considerations often guide the choice.

Neurontin should be stored at room temperature, below 25 °C, in its original container. Protect the product from moisture, excessive heat, and direct sunlight to maintain its stability and potency.

Neurontin is taken orally, usually with or without food, as directed by the prescribing clinician. The tablets or capsules are swallowed whole with a glass of water and should be taken at the same times each day to maintain consistent blood levels.

Serious risks include severe skin reactions (e.g., Stevens‑Johnson syndrome), suicidal thoughts or behavior, and respiratory depression, especially when combined with other central nervous system depressants. Patients should be monitored closely for any of these signs.

Neurontin is contraindicated in individuals with known hypersensitivity to gabapentin or any of its excipients. Caution is also advised for patients with severe renal impairment, as dose adjustments are required, and for those taking medications that may cause additive CNS depression.